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Goal-directed actions are sensitive to work-related response costs, and dopamine in nucleus accumbens is thought to modulate the
exertion of effort in motivated behavior. Dopamine-rich striatal areas such as nucleus accumbens also contain high numbers of adeno-
sine A2A receptors, and, for that reason, the behavioral and neurochemical effects of the adenosine A2A receptor agonist CGS 21680
[2-p-(2-carboxyethyl) phenethylamino-5-N-ethylcarboxamidoadenosine] were investigated. Stimulation of accumbens adenosine A2A
receptors disrupted performance of an instrumental task with high work demands (i.e., an interval lever-pressing schedule with a ratio
requirement attached) but had little effect on a task with a lower work requirement. Immunohistochemical studies revealed that accum-
bensneurons that project to the ventral pallidumshowedadenosineA2A receptors immunoreactivity.Moreover, activationof accumbens
A2A receptors by local injections of CGS 21680 increased extracellular GABA levels in the ventral pallidum. Combined contralateral
injections of CGS 21680 into the accumbens and the GABAA agonistmuscimol into ventral pallidum (i.e., “disconnection”methods) also
impaired response output, indicating that these structures are part of a common neural circuitry regulating the exertion of effort. Thus,
accumbens adenosine A2A receptors appear to regulate behavioral activation and effort-related processes by modulating the activity of
the ventral striatopallidal pathway. Research on the effort-related functions of these forebrain systemsmay lead to a greater understand-
ing of pathological features of motivation, such as psychomotor slowing, anergia, and fatigue in depression.
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Introduction
Striatal function is modulated by several neurotransmitters, in-
cluding amino acids, dopamine (DA), acetylcholine (Surmeier,
2006), and the purine nucleoside adenosine (Fredholm and Sven-
ningsson, 2003; Fuxe et al., 2007; Schiffmann et al., 2007; Ferre´,
2008). Adenosine acts on G-protein-coupled receptors, and the
A2A receptor subtype is highly concentrated in neostriatum and
nucleus accumbens (Rosin et al., 1998; Svenningsson et al., 1999;
Hettinger et al., 2001). There is an interaction between striatal
A2A receptors and DA D2 receptors, and adenosine A2A receptor
blockade can antagonize motor deficits induced DA depletions or
antagonism (Correa et al., 2004; Morelli et al., 2007; Salamone et
al., 2008). Adenosine A2A antagonists are being assessed for anti-
parkinsonian effects in clinical trials (Schwarzschild et al., 2006;
Morelli et al., 2007), and A2A receptors contribute to the stimu-
lant effects of nonselective adenosine antagonists such as caffeine
(Ferre´, 2008).
Stimulation of neostriatal adenosine A2A receptors induces
motor effects that resemble those of DA antagonists (Wardas et
al., 2003), but less is known about the role of accumbens A2A
receptors (Hauber and Munkle, 1997; Ishiwari et al., 2007). Nu-
cleus accumbens DA modulates the performance of goal-directed
behaviors and is involved in various aspects of instrumental
learning and motivation (Ikemoto and Panksepp, 1996; Salam-
one and Correa, 2002; Kelley, 2004; Barbano and Cador, 2007;
Berridge, 2007; Robbins and Everitt, 2007; Salamone et al., 2007).
An important function of accumbens DA is the modulation of
behavioral activation and effort-related processes. Accumbens
DA is particularly important for tasks that require substantial
effort to obtain the goal (Salamone et al., 2002, 2005, 2007).
Accumbens DA depletions alter effort-related choice (Salamone
et al., 1991, 2007) and disrupt operant responding substantially
in schedules with high effort demands (Aberman and Salamone,
1999; Salamone et al., 2001). One way of varying effort demands
in operant tasks is to control the ratio requirement (i.e., number
of lever presses needed to receive reinforcement). Whereas fixed
ratio 1 (FR1) performance is resistant to the effects of accumbens
DA depletions, tasks with higher ratio requirements (e.g., FR5–
FR64) are more easily disrupted (Aberman and Salamone, 1999).
This effect occurs even if one controls for the amount of time
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between reinforcements; DA depletions disrupted lever pressing
when a FR5 or FR10 requirement was attached to variable time
intervals of 30, 60, or 120 s but not when an FR1 was attached
(Correa et al., 2002; Mingote et al., 2005). In the present experi-
ments, we investigated whether the adenosine A2A agonist
CGS 21680 [2-p-(2-carboxyethyl) phenethylamino-5-N-ethyl-
carboxamidoadenosine] would also interact with the ratio re-
quirement by differentially affecting performance on time-
controlled schedules (variable interval, 60 s) with two different
requirements (FR1 vs FR10) (Mingote et al., 2005). It was hy-
pothesized that accumbens A2A receptor stimulation would pro-
duce effects similar to accumbens DA depletions. The accumbens
core subregion was studied because, compared with the shell, this
region is richer in adenosine A2A receptor immunoreactivity
(Rosin et al. 1998) and is more sensitive to the locomotor effects
of A2A antagonists (Ishiwari et al. 2007). Furthermore, we studied
the anatomy, neurochemistry, and behavioral significance of
GABAergic ventral striatopallidal neurons, which project from
nucleus accumbens to ventral pallidum (VP) and are hypothe-
sized to contain adenosine A2A receptors (Robertson and Jian,
1995; Ferre´, 1997). VP is thought to function as a relay area and
an integrator of striatal and limbic inputs (Hooks and Kalivas,
1995; Kretschmer, 2000; Tindell et al., 2004; Farrar et al., 2008).
We determined the effects of intra-accumbens injections of CGS
21680 on GABA release in VP and used “disconnection” methods
to study the combined and separate effects of accumbens adeno-




Male Sprague Dawley rats (290 –350 g; Harlan Sprague Dawley) were
maintained at 23°C with a 12 h light/dark cycle. Behavioral testing oc-
curred during the light part of cycle (9:00 A.M. to 6:00 P.M.). Except
during postoperative recovery, rats were food restricted to 12–14 g/d.
Water was available ad libitum in the home cages. Animals were housed
in pairs before surgery and singly afterward, and different groups of
animals were used for each experiment. Experimental methods were in
accordance with the Guide for the Care and Use of Laboratory Animals,
National Research Council.
Behavioral procedures and presurgery acquisition
Behavioral experiments were conducted in operant chambers (30 24
21 cm; Med Associates), and 45 mg Bioserve Pellets were used as rein-
forcers. Animals were trained for 30 min sessions 5 d/week during the
light part of the light/dark cycle for 5 weeks before surgery and 4 weeks
after surgery. After 1 week of FR1 training, rats were trained on one of
two schedules of reinforcement for 5 weeks: a variable interval (VI) 60 s
schedule with a FR1 requirement attached to the interval requirement
(VI60/FR1) or a VI 60 s schedule with FR10 attached (VI60/FR10) as
described previously (Mingote et al., 2005). For the VI60/FR1 schedule,
rats were reinforced for the first response after each variable interval
elapsed. Rats on VI60/FR10 schedule were required to make 10 responses
after each interval elapsed to receive reinforcement. In both cases, the
particular interval varied around an average time requirement of 60 s;
this limited the programmed density of reinforcement to a maximum of
30 pellets per session.
Behavioral measures during the acquisition and testing phase of all
behavioral studies included number of food pellets obtained, number of
lever presses, and inter-response times (IRTs) (i.e., time between the
onset of two consecutive responses). IRTs were assigned to 1 s bins, and
the following time bins were recorded: bin 1, 0 –1 s; bin 2, 1–2 s; bin 3, 2–3
s; bin 4, 3– 4 s; bin 5, 4 –5 s; bin 6, 5– 6 s; bin 7, 6 –7 s; bin 8, 7– 8 s; bin 9,
8 –9 s; bin 10, 9 –10 s; bin 11, 10 –11 s; bin 12, 11–12 s; bin 13, 12–13 s; bin
14, 13–14 s; bin 15, 14 –15 s; bin 16, 15–16 s; bin 17, 16 –17 s; bin 18,
17–18 s; bin 19, 18 –19 s; bin 20, 19 –20 s; and bin 21, 20 s. The last IRT
bin was designated as a pause.
Surgery
Before surgery, animals were anesthetized with a ketamine/xylazine so-
lution (1.0 ml/kg, i.p.; 10 ml of 100 mg/ml ketamine plus 0.75 ml of 20
mg/ml xylazine). Guide cannulas made with 25 gauge extra-thin-walled
stainless steel tubing (Small Parts) were implanted 1.0 mm dorsal the
target site. The following coordinates were used for accumbens place-
ments: 2.8 mm anterior from bregma, 1.8 mm lateral from the midline,
6.8 –7.0 mm ventral from the skull surface; the incisor bar was set 5.0 mm
above the interaural line. The VP coordinates were as follows: 0.8 mm
anterior from bregma, 2.6 mm lateral from midline, and 7.0 mm ventral
from skull surface; the incisor bar was set between 3.2 and 4 mm
below the interaural line. In the microdialysis experiment, rats received
unilateral implantations of a 10 mm microdialysis guide cannula (Bio-
analytical Systems) at the same coordinates used for cannulas implants,
except that the dorsal/ventral coordinates were adjusted to6.8 mm to
allow for the size of the probe. Cannulas were secured to the skull by
stainless steel screws and polycarboxylate cement (Durelon; 3M ESPE
Dental Products); a stylet was inserted through each cannula to ensure its
integrity.
Drugs and intracranial injections procedures
CGS 21680 was obtained from Tocris Cookson. This drug was used
because it has been used as a ligand for striatal adenosine A2A receptors
for several years (Jarvis et al., 1989; Cunha et al., 1996). CGS 21680
binding in nucleus accumbens is abolished in adenosine A2A receptor
knock-out mice but not in A1 receptor knock-out mice (Halldner et al.
2004). For systemic injections, the drug was dissolved in 2% dimethyl-
sulfoxide solution (Fisher Scientific), and this solution served as the ve-
hicle control. For intracranial injections, CGS 21680 was dissolved in
0.9% saline. Muscimol hydrochloride was obtained from Sigma-Aldrich
and dissolved in saline for intracranial injections. In all behavioral exper-
iments, intracranial injections were made via 30 gauge stainless steel
injectors extending 1.0 mm beyond the guide cannulas. Injectors were
attached to 10 l Hamilton syringes by polyethylene PE-10 tubing. In-
jection volume was 0.5 l/side (0.125 l/min for 4 min). Injectors were
left in place for 1 min after the infusion to allow for drug diffusion.
Behavioral experiments
Effects of systemic injections of CGS 21680 on operant responding. Trained
rats received intraperitoneal injections of CGS 21680 (vehicle, 0.05, 0.1,
and 0.2 mg/kg; VI60/FR1, n  12; VI60/FR10, n  12). Injections were
given 15 min before the 30 min session began. Each rat received all drug
treatments in a randomly varied order (one treatment per week; within-
groups design). Baseline training sessions were conducted 4 additional
days per week.
Effects of intra-accumbens injections of CGS 21680 on operant respond-
ing. Additional groups of trained rats were surgically implanted with
bilateral accumbens cannulas. After recovery (7–10 d), rats were trained
for 2 additional weeks on their presurgery schedules. On the test day,
animals received bilateral intracranial injections of CGS 21680 and were
immediately placed in the operant boxes and tested for 30 min. Each
animal received one of the following doses of CGS 21680 (dissolved in
saline vehicle): saline vehicle (VI60/FR1, n 7; VI60/FR10, n 7), 3.0 ng
(VI60/FR1, n  7; VI60/FR10, n  6), or 6.0 ng (VI60/FR1, n  8;
VI60/FR10, n 6). The dorsal control groups were trained on the VI60/
FR10 schedule and received bilateral injections of either vehicle (n 5)
or 6.0 ng of CGS 21680 (n 6).
Effects of a functional disconnection procedure on operant responding. A
third batch of rats were trained for 5 weeks on the VI60/FR10 schedule for
the disconnection experiment. After postsurgical training, rats received
injections of either vehicle or 24.0 ng of CGS 21680 in the accumbens,
plus treatment with either vehicle or 1.25 ng of muscimol hydrochloride
in the contralateral VP. Injections were counterbalanced for left and right
placements. Animals were randomly assignment to one of the following
four combined drug/site treatment conditions, which followed a 2  2
factorial design: vehicle/accumbens plus vehicle/VP (n  6), vehicle/
accumbens plus 1.25 ng of muscimol/VP (n 7), 24.0 ng of CGS 21680/
accumbens plus vehicle/VP (n  5), and 24.0 ng of CGS 21680/accum-
bens plus 1.25 ng of muscimol/VP (n  6). The control experiment for
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this study involved two groups of animals that received ipsilateral injec-
tions of drug or vehicle; the drug group received 24 ng of CGS 21680 into
the accumbens combined with 1.25 ng of muscimol into the ipsilateral
VP (n 6), whereas the vehicle group (n 5) received saline injections
in both structures.
Double labeling of nucleus accumbens projection neurons
For the anatomical tracing experiment, cholera-toxin B (CTB 488; In-
vitrogen) was injected into VP 1 week before perfusion (n 6), to allow
retrograde transport of the tracer to the accumbens. For double labeling,
each antigen was detected using different chromogens. CTB was visual-
ized using 3,3 diaminobenzidine (DAB) (brown), and A2A receptors
were visualized using Vector vasoactive intestinal peptide (V-VIP) (Vec-
tor Laboratories) (purple). When processing the tissue, the immunohis-
tochemical protocol for CTB was conducted first, followed by the A2A
receptor protocol. Brains were fixed using 3.7% formaldehyde solution
and sliced with a vibratome (40m sections). The protocol used for CTB
visualization has been described previously (Farrar et al., 2008). Endog-
enous peroxidase activity was blocked with a 20 min incubation in 0.5%
hydrogen peroxide (H2O2) plus 1% methanol in PBS at room tempera-
ture on a shaker table. Free-floating sections were rinsed in PBS (three
times for 10 min) and then permeabilized and blocked in a solution with
0.2% Triton X-100 and normal goat serum (NGS) (Vector Laboratories)
for 1 h in PBS. Sections were incubated in the primary antibody rabbit
anti-CTB (1:5000; Sigma-Aldrich) and NGS for 16 h at 4°C. After three
PBS rinses, sections were incubated in the secondary antibody biotinyl-
ated goat anti-rabbit (1:200; Vector Laboratories) and NGS for 2 h at
room temperature. Tissue was rinsed again (three times for 10 min) and
incubated in a PBS, Triton X-100, avidin– biotin solution (ABC kit;Vec-
tor Laboratories) for 1 h at room temperature. After rinsing (three times
for 10 min), tissue was incubated in a solution containing buffer, H2O2,
and DAB (Vector Laboratories) for 2–10 min at room temperature and
rinsed a final time (three times for 10 min). Some of the retrogradely
labeled tissue sections were cleared in Citrosolve, mounted on slides, and
coverslipped for light microscopy observations. The rest of the sections
were further processed for the visualization the A2A receptors. In this
case, the free-floating tissue was again exposed to a hydrogen peroxide
solution for 5 min followed by a water rinse. Subsequently, tissue was
mounted on plus slides and immersed in preheated low pH antigen
retrieval (DakoCytomation) for 20 min. After the sections were cooled
and rinsed three times in PBS, the primary antibody mouse monoclonal
anti-adenosine receptor A2A (1:1000; dissolved in bovine serum albu-
min; Upstate) was applied and incubated overnight at 4°C. Slides were
rinsed in PBS and incubated in the secondary antibody horse anti-mouse
(Envision HPR Monoclonal; DakoCytomation) for 1 h. After three
rinses in PBS, the reaction was visualized with V-VIP (Vector Laborato-
ries). The sections were allowed to air dry, cleared in Citrosolve, and
coverslipped for microscopic observation.
GABA microdialysis procedure and quantification
A unilateral guide cannula was implanted for the VP microdialysis,
whereas an injection cannula was implanted in the ipsilateral accumbens.
After recovery (7–10 d), rats were habituated to the microdialysis boxes
for 2 d. On sample collection day, dialysis probes (Bioanalytical Systems)
were inserted through the microdialysis guide cannulas early in the
morning. Dialysis samples were collected every 30 min. Artificial CSF (in
mM: 147.2 NaCl, 2.4 CaCl2, and 4.0 KCl) was continuously pumped
through the probe (2.0 l/min). The last two samples before treatment
were used as baseline samples. In the last 5 min of the last baseline sample,
rats received intra-accumbens injections of either vehicle (n 6) or 24.0
ng of CGS 21680 (n  9). Five samples were collected after injection.
Samples were frozen and analyzed for GABA content using reverse-phase
HPLC with electrochemical detection (ESA). The HPLC analysis of
GABA content required a preinjection derivatization that was accom-
plished using o-phthalidialdehyde; all HPLC methods used have been
described previously (Trevitt et al., 2002; Correa et al., 2003; Ishiwari et
al., 2004).
Histology
After behavioral testing, animals were anesthetized with CO2 and per-
fused intracardially with physiological saline followed by 3.7% formal-
dehyde. Brains were stored in formaldehyde and then cryoprotected in a
30% sucrose solution for 3 d before being sliced with a cryostat in 50m
sections. Slices were stained with cresyl violet and examined by an ob-
server who was unaware of the experimental treatment. Any animal with
improper cannula placement or significant damage around the injection
site was excluded from the analyses of behavioral data (30% of implan-
tations were rejected).
Statistical analyses
The effects of systemic CGS 21680 injections were analyzed using 2
(schedule)  4 (dose) two-way ANOVAs, with dose as the within-
subjects factor. ED50 values were estimated using nonlinear regression
analysis (GraphPad Prism). The exponential dose–response function was
constrained to a minimum of zero and a maximum of the vehicle mean.
Behavioral effects of the bilateral intracranial injections of CGS 21680
into the nucleus accumbens were analyzed using a between-subjects 2
(schedule)  3 (dose) two-way ANOVA. For IRT data analyses, two
parameters were singled out for statistical analyses: fast responses (IRTs
1.0 s) and pauses (IRTs 20.0 s). These parameters were analyzed
using a 2 (schedule)  3 (dose) two-way ANOVA. The use of these
measures was based on previous research (Sokolowski and Salamone,
1998; Correa et al., 2002; Mingote et al., 2005). Significant interactions
that were indicative of treatment-specific IRT effects were further ana-
lyzed for simple effects using the error terms from the specific analyses.
For the dorsal control experiment, behavioral data were analyzed using a
one-way ANOVA. Behavioral data for the disconnection experiment
were analyzed using between-subjects 2 (placement) 2 (drug) factorial
ANOVA. Neurochemical data for the microdialysis experiment were
Figure 1. Effects of systemic injections of CGS 21680 on two interval operant scheduleswith
different ratio requirements attached: VI60/FR1 and VI60/FR10. a, Suppressant effects of dif-
ferent doses of CGS 21680 on lever-pressing behavior. *p 0.05, VI60/FR10, different from
vehicle; p0.05, VI60/FR1, different fromvehicle.b, ED50 analysis also showed significantly
higher sensitivity to the effect of CGS 21680 on VI60/FR10 compared with VI60/FR1. The ED50
value for VI60/FR10was 0.06mg/kg, and the ED50 value for VI60/FR1was 0.1mg/kg. These two
values for the different scheduleswere significantly different, i.e., the 95% confidence intervals
(CI) for both schedules did not overlap (confidence interval for VI60/FR10, 0.05–0.07 mg/kg;
confidence interval for VI60/FR1, 0.08–0.14 mg/kg).
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transformed into percentage of baseline values.
The 100% value was the average of the last two
samples before the intracranial injection of CGS
21680 into the accumbens. The percentage of
baseline was analyzed using within-subjects 2
(treatment)  7 (sample) two-way ANOVA
and by orthogonal analysis of trend. Additional
analyses of the microdialysis data were con-
ducted by performing analysis of covariance
(ANCOVA) of the postinjection data, using the
last baseline sample as the covariate. This
method also is a way of correcting for variability
in baseline GABA levels across animals. For all
ANOVA calculations, a computerized statisti-
cal package (SPSS 10.1) was used (  0.05).
Interaction comparisons and simple main effects
using the error term from individual analyses
were conducted to determine the sources of inter-
action effects. Planned comparisons using the
overall error term were used to assess the differ-
ences between each dose and the control condi-
tion, which kept the total number of comparisons
to the number of conditions minus one.
Results
Effort-related behavioral effects of
adenosine A2A receptor stimulation
The first experiment studied the effects of
systemic administration of the adenosine
A2A agonist CGS 21680 on lever-pressing
behavior in two operant schedules of
reinforcement: a low-ratio-requirement
schedule (VI60/FR1) and a high-ratio-
requirement schedule (VI60/FR10). The
interval requirement was added so that
both schedules would have the same pro-
grammed density of reinforcement over
time. Systemic administration of CGS
21680 (saline vehicle, 0.05, 0.1, 0.2 mg/kg),
produced an overall significant drug effect
on both schedules of reinforcement (Fig.
1a). Nevertheless, it was evident that the
VI60/FR10 schedule was much more sen-
sitive to the effects of CGS 21680 than the
VI60/FR1 schedule. There was a significant
dose  schedule interaction (F(3,54) 
25.725; p  0.001), and the ED50 (i.e., the
dose that produced half-maximal respond-
ing) was lower for the VI60/FR10 schedule
than for the VI60/FR1 schedule (Fig. 1b).
These schedule differences were much
more apparent after intracranial injections
of CGS 21680 directly into nucleus accum-
bens (Fig. 2a). In experiment 2, there was a
robust scheduledose interaction (F(2,35)
13.5; p 0.001). Furthermore, there was a significant main effect of
CGS 21680 treatment among those rats performing on the VI60/
FR10 schedule (F(1,16) 19.833; p 0.001) but no effect for the rats
performing on the VI60/FR1 schedule. A factorial ANCOVA with
baseline response rate as the covariant was also performed to deter-
mine whether the dose  schedule interaction was an artifact of
different baseline response rates. As expected, this ANCOVA elimi-
nated the overall differences between schedules, but there was still a
significant overall effect of dose (F(2,34) 22.727; p 0.001) and a
significant dose schedule interaction (F(2,34)15.721;p0.001).
This indicated that the interaction was not simply an artifact of dif-
ferent baseline rates of responding on the two schedules and dem-
onstrated that local stimulation of accumbens adenosine A2A recep-
tors had a preferential effect on the VI schedule with the added ratio
requirement (i.e., VI60/FR10). These effects of intra-accumbens
CGS 21680 were site specific, because injections into a control site
dorsal to the nucleus accumbens had no significant effect (mean
SEM number of responses were as follows: vehicle, 1533.0 195.6;
6.0 ng of CGS 21680, 1683.5 190.4) .
The effects of CGS 21680 were further characterized by de-
Figure 2. Effects of local intra-accumbens injections of CGS 21680 on lever pressing on two variable interval schedules with
different ratio requirements.a, StimulationofA2A receptors in the accumbenshadnoeffect onVI60/FR1performancebut induced
a substantial decrease in responding in variable interval schedule with the higher ratio requirement attached (*p  0.05,
VI60/FR10, different from vehicle). b, c, Cannula placements from intracranial injections in animals trained in the VI60/FR10 and
the VI60/FR1 schedules, respectively, were localized in the nucleus accumbens (Nac) core. d, Cannulas placements for the dorsal
control site. c, d, Modified from Paxinos andWatson (1997), their Figures 11–13.
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tailed analyses of the IRTs. Several previous studies reported that
attaching a ratio requirement to a schedule presents a challenge to
the animal, and rats adapt to this obstacle by increasing responses
rates and showing a characteristic “bursting” pattern of responses
(Sokolowski and Salamone, 1998; Salamone et al., 1999; Correa et
al., 2002; Mingote et al., 2005). The present study showed that
vehicle-injected animals on the VI60/FR10 schedule emitted
more responses than those on the VI60/FR1 schedule, and this
difference was marked by a higher number of fast responses (IRTs
1 s) (Fig. 3a) in rats responding on the FR10 task. Intra-
accumbens injections of CGS 21680 suppressed the tendency to
emit a high number of fast responses, and this effect was the
principal cause for the substantial reduction of responding on the
VI60/FR10 schedule (F(2,16)  17.514; p  0.001). Thus, CGS
21680 injected into the accumbens is particularly disruptive of
tasks that demand higher work output and are characterized by
high local rates of responding. Nevertheless, the schedule with a
low work requirement (VI60/FR1) was not totally insensitive to
neurochemical manipulations, because accumbens A2A receptor
stimulation increased the tendency to take long pauses in re-
sponding in both schedules (Fig. 3b) (overall dose effect, F(2,35)
4.004; p 0.05). Although the number of pauses was affected in
both schedules, rats performing on a VI60/FR10 schedule spent
more time not responding. Drug-treated rats performing on the
schedule with the higher work requirement took a longer time to
reinitiate responding after taking a pause compared with rats
performing on the low-work-requirement task (Fig. 3c) (F(2,35)
4.004; p 0.05).
Overt signs of sedation were sometimes seen by experimenters
when they placed animals in and out of the operant chambers. In
the systemic injection experiment, it was noted that 0.1 and 0.2
mg/kg CGS 21680 injected intraperitoneally generally produced
observable signs of sedation/drowsiness (head down, eyes par-
tially closed, flattened posture). In contrast, intra-accumbens in-
jections did not produce this effect. Furthermore, drug-treated
animals in each experiment consumed all the operant pellets
presented.
Accumbens A2A receptor stimulation activates the ventral
striatopallidal pathway
Additional experiments investigated the effects of stimulating ac-
cumbens adenosine A2A receptors on the VP, which is the main
target of accumbens neurons. Track-tracing techniques com-
bined with immunohistochemical methods confirmed that nu-
cleus accumbens cells that project to VP contain adenosine A2A
receptor immunoreactivity. Injections of the retrograde label
CTB were mostly restricted to the dorsomedial or dorsolateral
compartments of VP, and the CTB-labeled cell bodies were
mostly found in accumbens core (Fig. 4a–c). In addition, these
retrogradely labeled neurons also expressed adenosine A2A recep-
tor immunoreactivity (Fig. 4d–f). These accumbens projection
neurons are GABAergic, and therefore we investigated the effect
of stimulation of accumbens A2A receptors on GABA release in
the VP. We measured extracellular GABA levels in VP before and
after intra-accumbens injections of CGS 21680 using microdialy-
sis methods (Fig. 5a). Intracranial injections of 24.0 ng of CGS
21680 significantly increased extracellular GABA levels in the VP.
Analyses across all seven samples showed a significant drug treat-
ment effect (F(1,13) 5.25; p 0.05) and a significant sample
treatment interaction (F(6,78)  2.4; p  0.05). Analysis of
simple effects demonstrated that the group that received CGS
21680 showed significantly higher levels of extracellular GABA
during each of the five samples after injection compared with
the group that received vehicle injections. Furthermore, or-
thogonal analysis of trend across all seven samples for the
percentage baseline data showed a significant sample treat-
ment interaction for the quadratic trend (F(1,13)  5.00; p 
0.05), indicating that VP GABA levels in the CGS 21680-
treated group showed an increase followed by a decrease,
whereas GABA levels for the vehicle group did not. Additional
analyses of raw GABA concentration levels (data not shown),
using an ANCOVA with the last sample before injection as
the covariant, also showed a significant effect of treatment
(F(1,12)  5.08; p  0.05).
Figure3. Effects of intra-accumbens injections of CGS 21680 on IRTs collectedwhile animals
were performing in two different interval schedules. a, CGS 21680 injections had a dramatic
dose-dependent suppressant effect of the number of fast responses (IRTs1 s) emitted on the
VI60/FR10 schedule (*p 0.05, VI60/FR10, different from vehicle). b, Effects of CGS 21680 on
the number of pauses (IRTs20.0 s) were independent of ratio requirement of the instrumen-
tal task ( #p 0.05, overall effect of CGS 21680 on pause number). c, Analysis of the total pause
time revealed that for the highest dose (6.0 ng) the rats performing on the VI60/FR10 are
pausing for longer time compared with the rats performing on the VI60/FR1 schedule (*p
0.05, significant difference between schedules).
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Disconnection experiment: combined
and separate effects of accumbens
adenosine A2A and VP GABAA receptor
stimulation indicate actions on
common neural circuitry
Increases in GABA transmission induced
by the stimulation of accumbens A2A re-
ceptors could indicate that accumbens
A2A receptors and VP GABA are part of a
common neural circuitry mediating
effort-related functions. To address this
question, the final experiment used dis-
connection methods to assess the possible
functional relationship between accum-
bens A2A and VP GABA receptor stimula-
tion. This experiment involved unilateral
injections of CGS 21680 or vehicle into the
accumbens core and contralateral injec-
tions of the GABAA receptor agonist mus-
cimol or vehicle into VP. Immediately af-
ter intracranial injections, animals were
put in test chambers and tested on the high
ratio task (VI60/FR10). We hypothesized
that there would be a substantial behav-
ioral effect only when CGS 21680 was in-
jected into the nucleus accumbens core
and muscimol was injected into the con-
tralateral VP, but not when there were uni-
lateral injections of either drug. Factorial
ANOVA revealed a significant place-
ment  drug interaction (F(3,19)  7.34;
p  0.01), and planned comparisons re-
vealed that only the group that received
combined contralateral drug injections
(i.e., CGS 21680 in the accumbens/musci-
mol in the contralateral VP) significantly
differed from the vehicle/vehicle control
group (Fig. 6a). This demonstrated that
combined administration of CGS 21680 in
the accumbens on one side of the brain
plus muscimol into the VP on the other
side resulted in a synergistic suppression of
operant responding compared with sepa-
rate unilateral injections of each drug. The present results were
not simply a consequence of the total amount of drug injected,
because combined ipsilateral injections of CGS 2168 into the
accumbens and muscimol into VP had no significant effect on
operant responding (mean SEM number of responses were as
follows: vehicle plus ipsilateral vehicle, 1394.0 129.0; 24.0 ng of
CGS 21680 plus ipsilateral VP muscimol, 1167.0 160.1).
Discussion
Motivated behavior often is characterized by vigor, persistence, and
high levels of work output (Salamone et al., 2007). The work require-
ments of an instrumental task can be manipulated in several ways,
including increases in the number of lever presses (i.e., the ratio)
required for reinforcement. Using operant schedules with different
ratio requirements, it was demonstrated that higher work require-
ments make animals more sensitive to the effects of the adenosine
A2A receptor agonist CGS 21680. Together with the results of ana-
tomical and neurochemical studies, the present behavioral experi-
ments indicate that adenosine A2A receptors located on accumbens
neurons projecting to the VP play an important role in behavioral
activation and regulate the tendency of organisms to overcome re-
sponse costs that separate them from reinforcement.
Local stimulation of accumbens adenosine A2A receptors had
a selective effect on the behavioral task with the higher ratio re-
quirement, which supports the hypothesis that stimulation of
accumbens adenosine A2A receptors would lead to effects similar
to those produced by accumbens DA depletions. Stimulation of
accumbens adenosine A2A receptors decreased total responses
and fast responses on the high ratio schedule, and increased frag-
mentation in the response pattern (i.e., increased pausing) on
both schedules, which also has been shown to occur after accum-
bens DA depletions (Mingote et al., 2005). This increased re-
sponse fragmentation may indicate problems initiating instru-
mental activity, a lack of task engagement, or difficulty in
responding to temporally unpredictable stimuli (Mingote et al.,
2005; Corbit et al., 2007; Nicola, 2007; Salamone et al., 2007).
Nevertheless, the fact that intra-accumbens CGS 21680 did not
produce an overall impairment of VI60/FR1 performance indi-
cates that two important components of instrumental behavior
were left intact: (1) animals were still capable of performing food-
Figure 4. Retrogradely labeled accumbens–VP neurons show A2A receptor immunoreactivity. a, Coronal section showing the
injection site of the retrograde tracer CTB in VP. Cells were counterstained with cresyl violet to enhance visualization. b, Coronal
section showing the retrogradely labeled neurons in the nucleus accumbens (Nac) core after the injection of the CTB into the VP.
c, Photomicrograph (20) taken from one section of the accumbens core showing retrogradely labeled cells. Transported CTB is
labeled brown with DAB. d, Coronal section showing the immunoreactivity of the A2A receptors (purple) in the striatal complex,
which includes the neostriatum, nucleus accumbens, and olfactory tubercles. The dashed line delineates the dark brown area of
the retrogradely labeled cells in the core region of the nucleus accumbens. e, Photomicrograph (40) taken from one section of
the accumbens core processed for dual labeling of CTB and A2A immunoreactivity. A brown reaction product (DAB) identified the
neurons retrogradely labeled with CTB (black triangles). A2A-immunoreactive neurons were labeled purple with V-VIP, and
double-labeled cells are indicated in the figurewith arrows. f, Highmagnification (100) showinga cell in the accumbensdouble
labeled with CTB (brown labeling), which was mainly localized in the neuronal soma (black triangle), and A2A receptor (purple
labeling), which was mainly localized in dendrites (arrow). AC, Anterior commissure; M, medial; L, lateral.
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reinforced behavior, and (2) the interval
requirement of the schedule (i.e., the in-
termittence) in itself did not appear to be a
significant factor in making animals sensi-
tive to adenosine A2A receptor manipula-
tions. Clearly, the ratio requirement of a
task is a critical factor in determining sen-
sitivity to the effects of nucleus accumbens
adenosine A2A receptor stimulation. These
results are consistent with studies involv-
ing accumbens DA depletions or antago-
nism (Cousins et al., 1996; Sokolowski and
Salamone, 1998; Salamone et al., 1999;
Wakabayashi et al., 2004; Mingote et al.,
2005; Winstanley et al., 2005; Floresco et
al., 2008).
Although systemic injections of CGS
21680 also produced a preferential effect
on the schedule with the larger ratio re-
quirement, at the higher doses used (0.1
and 0.2 mg/kg), intraperitoneal injections
of CGS 21680 suppressed responding on
both schedules. These results are likely to
be related to sedative effects (i.e., sleepi-
ness/drowsiness, torpor, head down, eyes
partially closed) that are known to be in-
duced by 0.1 and 0.2 mg/kg doses of CGS
21680 (Font et al., 2008; Mingote et al.,
2008). This suggestion is consistent with
the extensive literature showing that aden-
osine is involved in sleep and that several
brain areas, including basal forebrain and
the ventrolateral preoptic area, are in-
volved in the sedative functions of adeno-
sine (Porkka-Heiskanen et al., 2000; Sten-
berg, 2007). Intra-accumbens injections of
CGS 21680 appear to have avoided actions
on brain areas related to sedation and in-
duced effects that were clearly different for
both schedules. Consistent with this idea,
Font et al. (2008) recently reported that
systemic injections of 0.1 and 0.2 mg/kg
CGS 21680 induced observable signs of se-
dation/drowsiness in all rats, whereas in-
jections of 24.0 ng of CGS 21680 into nu-
cleus accumbens did not produce overt
sedation/drowsiness in any animals. The
behavioral effects produced by CGS 21680
in the present study were relatively specific
to nucleus accumbens, because injections
of the higher dose into the overlying dorsal
striatum had no effect on operant re-
sponding. This finding is consistent with
previous studies showing that DA deple-
tions or injections of CGS 21680 dorsal to
nucleus accumbens did not impair FR5
operant responding (Cousins et al. 1993;
Font et al., 2008).
Together, the anatomical, neurochem-
ical, and behavioral studies indicated that
the behavioral effects of CGS 21680 are in
part attributable to stimulation of adeno-
sine A2A receptors on GABAergic accum-
Figure 5. Accumbens injections of CGS 21680 increase extracellular GABA in the VP. a, Percentage of baseline GABA levels in
the VP before and after the injection of vehicle saline of CGS 21680 (24.0 ng, 0.5l/side) into the nucleus accumbens (Nac) core.
The last two baseline samples collected before the injection were used to compute the percentage of baseline GABA levels. *p
0.05, significantly different from vehicle. Preinjection baseline levels of GABA in the two groups did not differ (vehicle, 0.21
0.032 ng; CGS 21680, 0.15 0.020 ng; t 1.7; df 13; NS). By the second sample after injection, raw GABA levels in the two
groupswere as follows: vehicle, 0.16 0.019 ng; CGS 21680, 0.21 0.043 ng.b, Schematic of the intra-accumbens injections of
CGS21680or vehicle saline into thenucleus accumbens core and the simultaneous collectionofGABA samples in ipsilateral ventral
pallidum using microdialysis probe. c, Cannula placements into the accumbens core (modified from Paxinos and Watson, 1996,
their Figs. 11–13). d, Microdialysis probe placements into the VP (modified from Paxinos andWatson, 1996, their Figs. 18–21).
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bens neurons that project to VP. Nucleus
accumbens core neurons are known to
project to VP (Usuda et al., 1998; Zhou et
al., 2004), and a recent study showed that
the specific VP target area used in the
present experiments receives a projection
from accumbens core (Farrar et al., 2008).
The present studies showed that, after an
injection of the retrograde tracer CTB into
VP target area, the CTB-labeled cell bodies
were mostly found in accumbens core
(Fig. 4a–c) and also that these retrogradely
labeled accumbens core–VP neurons co-
expressed adenosine A2A receptor immu-
noreactivity (Fig. 4d–f). Thus, the present
studies directly demonstrated that accum-
bens core–VP projection neurons that
form part of the ventral striatopallidal
pathway also contain adenosine A2A re-
ceptor immunoreactivity. This finding
supports the circuitry model offered by
Ferre´ (1997), who suggested that accum-
bens neurons projecting to the VP contain
A2A receptors and also is consistent with
the report that Fos-like immunoreactivity
induced by CGS 21860 can be observed in
accumbens cells that are labeled by fluoro-
gold injected into VP (Robertson and Jian,
1995).
Intra-accumbens infusions of a behav-
iorally active dose of CGS 21680 (24.0 ng)
increased extracellular GABA levels in the
VP as measured by microdialysis (Fig. 5).
Previous work indicated that local admin-
istration of 50 ng of CGS 21680 into the
neostriatum increased extracellular GABA
levels in the globus pallidus (Ochi et al.,
2000). Moreover, coinfusion of the DA D2
receptor agonist quinpirole along with
CGS 21680, through a microdialysis probe
implanted in the accumbens, blocked the
increase in VP GABA levels induced by
CGS 121680 alone (Dı´az-Cabiale et al.,
2002). These findings are consistent with
reports showing that accumbens adeno-
sine A2A receptors are colocalized with D2
receptors in GABAergic enkephalin-
positive cells (Svenningsson et al., 1999) and further support the
hypothesis that DA D2 receptors and adenosine A2A receptors
have opposite effects on accumbens neuron activity (Fredholm
and Svenningsson, 2003). The cellular mechanisms underlying
the effects of A2A receptor stimulation may involve increased
cAMP production attributable to the activation of postsynaptic
adenosine A2A receptors (Svenningsson et al., 1999; Schiffmann
et al., 2007) and a consequent increase in spiny neuron excitabil-
ity (Colwell and Levine, 1995). Another possibility is presynaptic
or postsynaptic mechanisms that involve heterodimerization
with D2 receptors (Schiffmann et al., 2007; Ferre´, 2008). A2A re-
ceptors are located on glutamate terminals in striatum, and local
injections of CGS 21680 have been shown to increase striatal
glutamate release (Schiffmann et al., 2007; Ferre´, 2008). Never-
theless, regardless of the particular combination of mechanisms
that is involved, it appears that the net effect of activating accum-
bens adenosine A2A receptors is to increase GABA transmission
in VP. VP injections of the GABAA agonist muscimol can de-
crease novelty-induced motor activity and alter effort-related
choice behavior (Hooks and Kalivas, 1995; Farrar et al., 2008).
These behavioral effects are similar to those produced by accum-
bens DA depletions or antagonism (Nowend et al., 2001; Correa
et al., 2002; Farrar et al., 2008). Such results, together with the
present data, suggest that VP GABA transmission is involved in
mediating some of the behavioral effects of DA and adenosine
manipulations in nucleus accumbens.
The final experiment clearly showed that VI60/FR10 perfor-
mance was disrupted after unilateral intra-accumbens injections
of CGS 21680 combined with injections of the GABAA agonist
muscimol into the contralateral VP. Separate unilateral injec-
tions of each drug, and combined ipsilateral injections of both
drugs, were ineffective. This type of disconnection methodology
Figure 6. Number of lever presses emitted by animals in the disconnection experiment. a, Only animals injected with CGS
21680 into the nucleus accumbens (Nac) and muscimol into the contralateral VP showed decreased lever pressing. *p 0.05,
significantly different from vehicle/vehicle group. b, Cannulas placements in the accumbens core for the animals that were in the
CGS 21680/muscimol contralateral injection group (modified from Paxinos and Watson, 1996, their Figs. 11–13). c, Cannula
placements in the ventral pallidum for the animals that were in the CGS 21680/muscimol contralateral injection group (modified
from Paxinos and Watson, 1996, their Figs. 19–21). Placements were in the posterior/lateral zone of the VP (placement target
was based on Farrar et al., 2008; specific VP subregions were not targeted).
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has been useful for studying how distinct brain areas or systems
are part of an interconnected functional circuitry (Christakou et
al., 2004; Floresco and Ghods-Sharifi, 2007). Thus, the results of
the present experiments indicate that nucleus accumbens and VP
are part of a common neural circuitry regulating response output
in instrumental tasks with high work requirements. Currently,
considerable emphasis is being placed on the neuronal mecha-
nisms underlying effort-related processes. Effort-related dys-
functions such as psychomotor slowing or anergia have been
reported to be a central feature of depression (Stahl, 2002; Salam-
one et al., 2006). Nucleus accumbens and VP appear to be part of
a larger forebrain circuit regulating behavioral activation and
effort-related choice, which includes the prefrontal/anterior cin-
gulate cortex and the amygdala (Hooks and Kalivas, 1995; Cous-
ins et al., 1996; Sokolowski and Salamone, 1998; Nowend et al.,
2001; Walton et al., 2003; Denk et al., 2005; Schweimer et al.,
2005; Salamone et al., 2006, 2007; Floresco and Ghods-Sharifi,
2007; Farrar et al., 2007, 2008). The present results implicate
accumbens adenosine A2A receptors as an additional mechanism
through which this larger forebrain circuit can be regulated. Ac-
tivation of these receptors affected extracellular GABA in the VP,
and this stimulation of GABAergic activity in VP appears to be a
factor influencing behavioral output. Future research should de-
termine whether local blockade of VP GABAA receptors attenu-
ates the behavioral effects of stimulation of accumbens adenosine
A2A receptors and should investigate the effects of adenosine A2A
receptor knock-outs (Shen et al., 2008). Additional assessments
of this circuitry should involve disconnection studies that include
dopaminergic manipulations of nucleus accumbens and condi-
tions that affect the amygdala and prefrontal cortex, as well as
treatments related to adenosine and GABA.
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